Alimentiv is a global full-service GI-focused Clinical Research Organization (CRO) with 30+ years of experience offering comprehensive end-to-end clinical trial services and advanced imaging solutions.
We are a trusted partner for leading pharmaceutical & biotech companies, supporting >70% of IBD compounds currently in development. Our extensive network of 5,000+ global sites ensures rapid study activation and maximizes patient enrollment success. Alimentiv’s unmatched expertise in GI and liver-associated diseases spans all trial phases, for a variety of complex trials, including adaptive and virtual designs.As pioneers in central image management for endoscopy in inflammatory bowel diseases (IBD), we have set the gold standards for imaging endpoints in clinical trials. Alimentiv combines extensive GI medical & clinical expertise with innovative imaging technologies, like the industry-leading Notō custom software solution for image review, central reading scoring workflow and data scoring for endoscopy (CIMS Plus™, CIMS AVC™), histopathology (Lucidity™) and DICOM (magnetic resonance imaging/enterography (MRI/MRE & intestinal ultrasound (IUS)).
We also offer cutting-edge precision medicine and translational research services, with access to our specialty histopathology laboratory, AcelaBio, to support all your biomarker discovery projects.Our commitment to GI clinical research is reflected in our collaborations with leading GI experts and key opinion leaders to develop and validate clinical trial outcome measures, our tailored clinical trial services for multi-center trials with an experienced GI team, and our innovative centralized imaging solutions that benefit patients, clinicians, investigators and our sponsors.
Join us at UEG Week to explore Alimentiv’s groundbreaking research, which is showcased across four posters.
When: October 12-15, 2024 in Vienna, Austria
Where: Messe Wien Exhibition Congress Center
Booth #57
